Literature DB >> 25412743

SUMO-mimicking peptides inhibiting protein SUMOylation.

Bo Zhao1, Eric B Villhauer, Karan Bhuripanyo, Hiroaki Kiyokawa, Hermann Schindelin, Jun Yin.   

Abstract

The ubiquitin-like protein SUMO is transferred through a core E1-E2 cascade composed of the SUMO-activating enzyme (SAE) and Ubc9 to modify cellular proteins and transmit important biological signals. SAE primarily recognizes the C-terminal tail of SUMO and catalyzes ATP condensation with the SUMO C-terminal carboxylate to activate its transfer through the cascade. Here, we used phage display to show that a broad profile of SUMO C-terminal sequences could be activated by SAE. Based on this, we developed heptamer peptides that could 1) form thioester conjugates with SAE, 2) be transferred from SAE to Ubc9, and 3) be further transferred to the SUMOylation target protein RanGAP1. As these peptides recapitulate the action of SUMO in protein modification, we refer to them as "SUMO-mimicking peptides". We found that, once the peptides were conjugated to SAE and Ubc9, they blocked full-length SUMO from entering the cascade. These peptides can thus function as mechanism-based inhibitors of the protein SUMOylation reaction.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  SUMO; SUMO activating enzyme; SUMOylation; peptide inhibitor; phage display

Mesh:

Substances:

Year:  2014        PMID: 25412743      PMCID: PMC4643655          DOI: 10.1002/cbic.201402472

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  44 in total

1.  A mechanism for inhibiting the SUMO pathway.

Authors:  Roberto Boggio; Riccardo Colombo; Ronald T Hay; Giulio F Draetta; Susanna Chiocca
Journal:  Mol Cell       Date:  2004-11-19       Impact factor: 17.970

Review 2.  SUMOylation in carcinogenesis.

Authors:  Kira Bettermann; Martin Benesch; Serge Weis; Johannes Haybaeck
Journal:  Cancer Lett       Date:  2011-11-02       Impact factor: 8.679

3.  A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.

Authors:  Jessica D Kessler; Kristopher T Kahle; Tingting Sun; Kristen L Meerbrey; Michael R Schlabach; Earlene M Schmitt; Samuel O Skinner; Qikai Xu; Mamie Z Li; Zachary C Hartman; Mitchell Rao; Peng Yu; Rocio Dominguez-Vidana; Anthony C Liang; Nicole L Solimini; Ronald J Bernardi; Bing Yu; Tiffany Hsu; Ido Golding; Ji Luo; C Kent Osborne; Chad J Creighton; Susan G Hilsenbeck; Rachel Schiff; Chad A Shaw; Stephen J Elledge; Thomas F Westbrook
Journal:  Science       Date:  2011-12-08       Impact factor: 47.728

Review 4.  SUMO: a multifaceted modifier of chromatin structure and function.

Authors:  Caelin Cubeñas-Potts; Michael J Matunis
Journal:  Dev Cell       Date:  2013-01-14       Impact factor: 12.270

5.  Specificity of the E1-E2-E3 enzymatic cascade for ubiquitin C-terminal sequences identified by phage display.

Authors:  Bo Zhao; Karan Bhuripanyo; Jeffrey Schneider; Keya Zhang; Hermann Schindelin; David Boone; Jun Yin
Journal:  ACS Chem Biol       Date:  2012-10-02       Impact factor: 5.100

6.  Inhibiting the protein ubiquitination cascade by ubiquitin-mimicking short peptides.

Authors:  Bo Zhao; Chan Hee J Choi; Karan Bhuripanyo; Eric B Villhauer; Keya Zhang; Hermann Schindelin; Jun Yin
Journal:  Org Lett       Date:  2012-11-07       Impact factor: 6.005

7.  Recognition of SUMO-modified PCNA requires tandem receptor motifs in Srs2.

Authors:  Anthony A Armstrong; Firaz Mohideen; Christopher D Lima
Journal:  Nature       Date:  2012-02-29       Impact factor: 49.962

8.  PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.

Authors:  A M Ishov; A G Sotnikov; D Negorev; O V Vladimirova; N Neff; T Kamitani; E T Yeh; J F Strauss; G G Maul
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

Review 9.  Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets.

Authors:  Lynn Bedford; James Lowe; Lawrence R Dick; R John Mayer; James E Brownell
Journal:  Nat Rev Drug Discov       Date:  2010-12-10       Impact factor: 84.694

Review 10.  Decoding the SUMO signal.

Authors:  Ronald T Hay
Journal:  Biochem Soc Trans       Date:  2013-04       Impact factor: 5.407

View more
  5 in total

Review 1.  SUMOylation in Glioblastoma: A Novel Therapeutic Target.

Authors:  Brandon M Fox; Andrew Janssen; Dagoberto Estevez-Ordonez; Florian Gessler; Nunzio Vicario; Gustavo Chagoya; Galal Elsayed; Houman Sotoudeh; William Stetler; Gregory K Friedman; Joshua D Bernstock
Journal:  Int J Mol Sci       Date:  2019-04-15       Impact factor: 5.923

Review 2.  Protein Engineering in the Ubiquitin System: Tools for Discovery and Beyond.

Authors:  Bo Zhao; Yien Che Tsai; Bo Jin; Bufan Wang; Yiyang Wang; Han Zhou; Tomaya Carpenter; Allan M Weissman; Jun Yin
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

Review 3.  Current Status of SUMOylation Inhibitors.

Authors:  Christopher M Brackett; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2021       Impact factor: 4.530

4.  Ubiquitin-Mimicking Peptides Transfer Differentiates by E1 and E2 Enzymes.

Authors:  Bo Jin; Jiayue Wang; Xiangnan Liu; Shuai Fang; Bo Jiang; Kay Hofmann; Jun Yin; Bo Zhao
Journal:  Biomed Res Int       Date:  2018-08-30       Impact factor: 3.411

Review 5.  SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.

Authors:  Karolin Eifler; Alfred C O Vertegaal
Journal:  Trends Biochem Sci       Date:  2015-10-22       Impact factor: 13.807

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.